Similar Articles
Sleep disturbances in Parkinson’s disease
Gülçin BENBİR, Derya KARADENİZ
Effects of Urodynamic Findings on Qualty of Life in Idiopathic Parkinson’s Disease
Ayhan ÖZTÜRK, Yıldız DEĞİRMENCİ, Fuat DEMİRCİ
Deep Brain Stimulation in Motion Disorders
Ayşegül GÜNDÜZ, Sabri AYDIN, Hülya APAYDIN, Güneş KIZILTAN, Sibel ERTAN,Bashar ABUZAYED, Semra OĞUZ, Selin YAĞCI
Relationship Between Dopaminergic Treatment and Sexual Behavior in Parkinson’s Disease
İlhan ATAGÜN, Aytül MUTLU, Feriha ÖZER, Birgül ATMACA, Sibel ÇETİN
Apomorphine Infusion in an Advanced Parkinson’s Disease Patient with Prominent Tremor Refractory to Oral Treatment Options
Dursun AYGÜN, Levent GÜNGÖR, Musa Kazım ONAR, Duran YAZICI
Lower Limb Oedema and Erytromelalgia Related with Cabergoline
Gülbün YÜKSEL, Figen VARLIBAŞ, Mehmet GENCER, Burçak ERGİN, Hülya TİRELİ
A Patient with Parkinsonism Secondary to Liver Disease
Emrah AYTAÇ, Arzu ALDEMİR, Selçuk ÇOMOĞLU
Parkinson’s Disease Tremor which Improved Following Thalamic Hematoma
Serhat ÖZKAN, Özcan ÖZDEMİR
Diagnosis and Treatment of Non-Motor Symptoms in Parkinson’s Disease
Dursun AYGÜN, Yakup TÜRKEL, Musa Kazım ONAR
Atypical parkinsonism syndromes
Gençer Genç
DOI: 10.5606/phhb.dergisi.2021.016
The freezing phenomenon in Parkinson’s disease
Nazlı Durmaz Çelik, Serhat Özkan
DOI: 10.5606/phhb.dergisi.2022.1
Comparison of plasma homocysteine levels and frequency of polyneuropathy in idiopathic Parkinsonian patients with healthy controls
Mehmet Balal, Miray Erdem, Elif Banu Söker, Meltem Demirkıran
DOI: 10.5606/phhb.dergisi.2023.32
Rare case of pramipexole-induced hiccups
Dilek İşcan, Zehra Yavuz, Burcu Gökçe Çokal, Selim Selçuk Çomoğlu
DOI: 10.5606/phhb.dergisi.2024.25
Wearable technologies for monitoring symptoms in Parkinson’s disease
Deniz Küsbeci, Kaan Kurtoğlu, Ozge Yilmaz Küsbeci
DOI: 10.5606/phhb.dergisi.2024.43
Balancing motor control and psychiatric stability: A five-year experience with apomorphine infusion in Parkinson’s disease and bipolar disorder
Nilüfer Büyükkoyuncu Pekel, Demet Yıldız
DOI: 10.5606/phhb.dergisi.2025.40
New molecule in Parkinson’s disease treatment: Safinamide (monoamine oxidase-B plus inhibitor)
Murat Gültekin, Beyzanur Altıkulaç Ilikhan
DOI: 10.5606/phhb.dergisi.2025.49
A case of Parkinson’s disease with clinical deterioration specific to constipation periods
Funda Kaplan, Zehra Yavuz, Özlem Munis Bizpınar, Selim Selçuk Çomoğlu
DOI: 10.5606/phhb.dergisi.2025.33